Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta del Mar (24)

2023

  1. Expression profile of microRNAs related with viral infectivity, inflammatory response, and immune activation in people living with HIV

    Frontiers in Microbiology, Vol. 14

2022

  1. Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response

    World Journal of Hepatology, Vol. 14, Núm. 1, pp. 62-79

  2. Implication of Neutrophils Extracellular Traps in the Pathogenesis of SARS-CoV-2 pneumonia

    Biomedicines, Vol. 10, Núm. 10

2021

  1. Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 9, pp. 1863-1871

  2. Modifications of liver stiffness and CXCL4, TGF-β1 and HGF are similar in HCV- and HIV/HCV-infected patients after DAAs

    Scientific Reports, Vol. 11, Núm. 1

  3. Neutrophil Expression of T and B Immunomodulatory Molecules in HIV Infection

    Frontiers in Immunology, Vol. 12

  4. Similarities and differences between hiv and sars-cov-2

    International Journal of Medical Sciences, Vol. 18, Núm. 3, pp. 846-851

2019

  1. Antiretroviral therapy partially improves the abnormalities of dendritic cells and lymphoid and myeloid regulatory populations in recently infected HIV patients

    Scientific Reports, Vol. 9, Núm. 1

  2. Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects

    Journal of Neuroimmune Pharmacology, Vol. 14, Núm. 3, pp. 413-422

2018

  1. Peripheral Th17 cells expressing β7 intestinal homing receptor in recent and chronic HIV infections

    Clinical and Experimental Immunology, Vol. 194, Núm. 3, pp. 350-360

2017

  1. Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock

    PLoS ONE, Vol. 12, Núm. 4

2016

  1. Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity

    World journal of gastroenterology, Vol. 22, Núm. 4, pp. 1433-1448

2015

  1. Immune activation response in chronic HIV-infected patients: Influence of hepatitis C virus coinfection

    PLoS ONE, Vol. 10, Núm. 3

2014

  1. Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patients

    PLoS ONE, Vol. 9, Núm. 7

  2. Protocolo diagnóstico diferencial de la nefropatía en un paciente con infección por el VIH

    Medicine (Spain), Vol. 11, Núm. 49, pp. 2924-2927

2013

  1. Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients

    PLoS ONE, Vol. 8, Núm. 6

2012

  1. La valoración de RNA del virus de la hepatitis C realizada a las 12 semanas de finalizar el tratamiento predice la respuesta virológica sostenida en enfermos con coinfección por VIH y VHC

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 1, pp. 15-17

2011

  1. Bacterial translocation in HIV-infected patients with HCV cirrhosis: Implication in hemodynamic alterations and mortality

    Journal of Acquired Immune Deficiency Syndromes, Vol. 56, Núm. 5, pp. 420-427

  2. Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: The role of bacterial translocation

    Liver International, Vol. 31, Núm. 6, pp. 850-858

2010

  1. Nocardiosis

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 10, Núm. 53, pp. 3545-3551